UBS
SwipeRx Equity Investment in Southeast Asia Healthcare
Pages
2
Time to read
5 mins
Publication
Language
English
Pages
2
Time to read
5 mins
Publication
Language
English
This document is a technical report detailing the SwipeRx equity investment aimed at improving healthcare access, efficiency, and patient outcomes in Southeast Asia, specifically in Indonesia, Cambodia, the Philippines, and Vietnam. It outlines the challenges faced by pharmacies in the region, where they serve as the primary point of care for patients, yet face significant operational difficulties due to a lack of resources and support. The report describes how SwipeRx, a leading pharmacy network, addresses these challenges through a comprehensive digital platform that connects pharmacy professionals and centralizes medication management. It highlights the impact of SwipeRx’s initiatives, including the participation of over 80,000 pharmacy professionals in digital medical courses and the significant reduction in medication errors. The report also discusses the franchise model aimed at empowering female pharmacists and the anticipated benefits of the Series B2 financing round to support further expansion and operational efficiency in the region.